Studies support new wound care for diabetic foot ulcers

Both the TCC-EZ and AMNIOEXCEL product lines, which focus on tissue regeneration, were cited in seven studies showing the effectiveness of these products in treating diabetic foot ulcers. These ulcers, which develop in nearly 25 percent of those with diabetes, are potentially life-threatening and sometimes can lead to amputations.

"Our portfolio has the most comprehensive line of evidence-based technologies across the continuum of care, providing clinicians with valuable integrated solutions to help remove barriers to healing, leading to better wound management and tissue repair," said Barry Wolfenson, group president of advanced wound care and pharmaceutical development, in a press release.